MétaCan
← all works

Immunosuppressive Drugs for Kidney Transplantation

2004· review· en· 1,524 citations· W1971278669 on OpenAlex· 10.1056/nejmra033540

Why is this work in the frame?

A frame that forgets how it found something cannot be audited. These are the routes that admitted this work.

Canadian affiliationAn author listed a Canadian institution. This is the only route the usual frame has.

Machine scores (provisional)

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Opus teacher head0.039
GPT teacher head0.366
Teacher spread
0.327 · how far apart the two teachers sit on this one work
Validation status
score_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Abstract

Suppression of allograft rejection is central to successful organ transplantation; thus, immunosuppressive agents are crucial for successful allograft function. Immunosuppressive drugs are used for induction (intense immunosuppression in the initial days after transplantation), maintenance, and reversal of established rejection. This review considers the use of immunosuppressive drugs in organ transplantation, focusing on renal transplantation.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

The record

Venue
New England Journal of Medicine
Topic
Renal Transplantation Outcomes and Treatments
Field
Medicine
Canadian institutions
University of Alberta
Funders
Keywords
MedicineImmunosuppressionTransplantationKidney transplantationOrgan transplantationIntensive care medicineGraft rejectionImmunologySurgery
Has abstract in OpenAlex
yes